Hudson Bay Capital Management LP Kymera Therapeutics, Inc. Transaction History
Hudson Bay Capital Management LP
- $25.3 Billion
- Q3 2025
A detailed history of Hudson Bay Capital Management LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 23,134 shares of KYMR stock, worth $1.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,134
Previous 23,134
-0.0%
Holding current value
$1.5 Million
Previous $1.31 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding KYMR
# of Institutions
222Shares Held
73.9MCall Options Held
144KPut Options Held
58.1K-
Baker Bros. Advisors LP New York, NY6.65MShares$432 Million3.07% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.35MShares$412 Million4.91% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$357 Million16.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.42MShares$352 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$337 Million0.05% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $3.55B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...